Sania Therapeutics
Alba Guijarro Belmar is currently the Head of Vector Development at Sania Therapeutics. Prior to this role, Alba worked as a Senior Scientist at the Sainsbury Wellcome Centre for Neural Circuits and Behaviour, where Alba focused on developing viral constructs for spinal neurons. Alba also has experience as a CK Senior Scientist at Eli Lilly and Company, and as a PhD student at the University of Aberdeen, where Alba studied spinal cord repair. With a background in neuroscience, Alba has also conducted research internships at Centro de Investigación Príncipe Felipe and INCLIVA Valencia Hospital Research Foundation.
This person is not in any teams
Sania Therapeutics
Sania Therapeutics is a gene therapy company that develops therapies that are specifically targeted to neural circuits.